4 reports

The total number of investigator reported adverse events, with ##, ## applications to date, is ## of which ## are reported as skin site reactions and ## triptan related adverse events.

  • Clinical Trial
  • Pharmaceutical
  • Transdermal Delivery
  • United States
  • Company

Additionally, M## demonstrated a similar safety profile as other triptans and no Serious Adverse Events (SAEs) were reported in the trial.

  • Clinical Trial
  • Transdermal Delivery
  • United States
  • Company
  • Aequus Pharmaceuticals Inc.

The company is in Phase I clinical trials for ZP-Triptan for the treatment of migraines.

  • Transdermal Delivery
  • Generex Biotechnology Corporation
  • Nitto Denko Corporation
  • Noven Pharmaceuticals, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • HIGHLIGHTS THE PIPELINE DISTRIBUTION OF THE DRUGS / VACCINES BASED ON MICRONEEDLE SYSTEMS.
  • TECHNOLOGY PROVIDERS

ZP-TRIPTAN IS A MICRONEEDLE BASED FORMULATION OF ZOLMITRIPTAN, BELONGING TO CLASS OF SEROTONIN RECEPTOR AGONISTS KNOWN AS TRIPTANS.

  • Transdermal Delivery
  • United States
  • Circassia Pharmaceuticals plc
  • Clearside Biomedical, Inc.
  • Zosano Pharma Corporation